Efficacy, tolerability, and safety of transition from beraprost to selexipag in patients with pulmonary arterial hypertension.
Phase of Trial: Phase II
Latest Information Update: 06 Jan 2017
At a glance
- Drugs Selexipag (Primary) ; Beraprost
- Indications Pulmonary arterial hypertension
- Focus Therapeutic Use
- 04 Jan 2017 Status changed from not yet recruiting to recruiting.
- 16 Dec 2016 New trial record